History of Drug Treatments Including Formularies,Current Situation and Strategy_Chinese Journal of Evidence-Based Medicine

Authors：

The UK Cochrane Centre, NHS R&D Programme, Summertown Pavilion, Middle Way, Oxford Oxfordshire OX2 TLG, UK;

Corresponding author：

Keywords：

Formulary; Prescribing; Evidence-Based medicine

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： Philip J Wiffen. History of Drug Treatments Including Formularies,Current Situation and Strategy. Chinese Journal of Evidence-Based Medicine, 2004, 04(5): 288-292. doi: Copy

1.	［1］Stolar MH. National survey of hospital pharmaceutical services1985[J]. Am J Hosp Pharm,1985 ;42(12): 2 667-2 278.
2.	［2］Muir Gray JA. How to make Health Policy and Management decisions [ M ] In: Evidence-based Healthcare. Edinburgh:Churchill Livingstone, 1997.
3.	［3］Sackett D, Brian Haynes R, Guyatt GH, Tugwell P. Clinical Epidemiology. A basis science for Clinical medicine [ M ].Boston/Toronto/London: Little, Brown & Co, 1991.
4.	［4］Jang R. Medicaid formularies: a critical review of the literature[J]. J Pharm Mark Manage, 1988; 2(3) :39 -61.
5.	［5］Kozma CM, Schulz RM, Dickson WM, Dye JT, Cox ER,Holdford DA, Michael L, Yates WN Jr, Young TL. Economic impact of cost-containment strategies in third party programmes in the US. Part Ⅱ [J]. Pharmacoeconomics,1993; 4(3) :187 -202.
6.	［6］Horn SD. Unintended consequences of drag formularies [ J ].Am J Health Syst Pharm, 1996; 53(18): 2 204-2 206.
7.	［7］Horn SD, Sharkey PD, Tracy DM, Horn CE, et al. Intended and unintended consequences of HMO cost containment strategies: results from the managed care outcomes project[J ].Am J Manag Care, 1996; 2(3) :253 -264.

1. ［1］Stolar MH. National survey of hospital pharmaceutical services1985[J]. Am J Hosp Pharm,1985 ;42(12): 2 667-2 278.
2. ［2］Muir Gray JA. How to make Health Policy and Management decisions [ M ] In: Evidence-based Healthcare. Edinburgh:Churchill Livingstone, 1997.
3. ［3］Sackett D, Brian Haynes R, Guyatt GH, Tugwell P. Clinical Epidemiology. A basis science for Clinical medicine [ M ].Boston/Toronto/London: Little, Brown & Co, 1991.
4. ［4］Jang R. Medicaid formularies: a critical review of the literature[J]. J Pharm Mark Manage, 1988; 2(3) :39 -61.
5. ［5］Kozma CM, Schulz RM, Dickson WM, Dye JT, Cox ER,Holdford DA, Michael L, Yates WN Jr, Young TL. Economic impact of cost-containment strategies in third party programmes in the US. Part Ⅱ [J]. Pharmacoeconomics,1993; 4(3) :187 -202.
6. ［6］Horn SD. Unintended consequences of drag formularies [ J ].Am J Health Syst Pharm, 1996; 53(18): 2 204-2 206.
7. ［7］Horn SD, Sharkey PD, Tracy DM, Horn CE, et al. Intended and unintended consequences of HMO cost containment strategies: results from the managed care outcomes project[J ].Am J Manag Care, 1996; 2(3) :253 -264.

Chinese Journal of Evidence-Based Medicine

History of Drug Treatments Including Formularies,Current Situation and Strategy

Abstract Full text Figures/Tables Video References Cited by

Format

Content